Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Swartling FJ
JSON
CSV
XLSX
TXT
Family name
Swartling
Given name
Fredrik J
Initials
FJ
ORCID
ORCID
0000-0002-8460-4367
Affiliations
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
12 publications
DOI
Crossref
A cytotoxic gene therapy targeting SOX9-positive therapy-resistant medulloblastoma
Lin T
, Hutter S,
Vikström E
, ...,
Giraud G
,
Swartling FJ
-
1
(1) - [2025-08-14; online 2025-09-08]
PubMed
DOI
Crossref
Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies.
Holmberg KO
,
Borgenvik A
,
Zhao M
, Giraud G,
Swartling FJ
Cancers (Basel)
16
(9) - [2024-04-30; online 2024-04-30]
DOI
Crossref
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Zhang X, Lu X, Zhong L, ...,
Chen X
, Sjoblom T
-
-
(-) - [2023-07-24; online 2023-07-24]
DOI
Crossref
Data from SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation
Adolphe C, Millar A,
Kojic M
, ...,
Genovesi LA
, Wainwright BJ
-
-
(-) - [2023-04-03; online 2023-04-03]
DOI
Crossref
Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Borgenvik A
,
Holmberg KO
,
Bolin S
, ...,
Weishaupt H
,
Swartling FJ
-
-
(-) - [2023-03-31; online 2023-03-31]
DOI
Crossref
Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Borgenvik A
,
Holmberg KO
,
Bolin S
, ...,
Weishaupt H
,
Swartling FJ
-
-
(-) - [2023-03-31; online 2023-03-31]
PubMed
DOI
Crossref
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Borgenvik A
,
Holmberg KO
,
Bolin S
, ...,
Weishaupt H
,
Swartling FJ
Cancer Res.
82
(24) 4586-4603 [2022-12-16; online 2022-10-12]
PubMed
DOI
Crossref
SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.
Adolphe C, Millar A,
Kojic M
, ...,
Genovesi LA
, Wainwright BJ
Mol. Cancer Res.
19
(11) 1831-1839 [2021-11-00; online 2021-07-30]
PubMed
DOI
Crossref
The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
Berg TJ,
Marques C
,
Pantazopoulou V
, ..., Squatrito M,
Pietras A
Cancer Res.
81
(8) 2101-2115 [2021-04-15; online 2021-01-22]
PubMed
DOI
Crossref
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.
Susanto E, Marin Navarro A, Zhou L, ...,
Falk A
,
Wilhelm M
Proc. Natl. Acad. Sci. U.S.A.
117
(33) 20127-20138 [2020-08-18; online 2020-08-03]
PubMed
DOI
Crossref
Medulloblastomics revisited: biological and clinical insights from thousands of patients.
Hovestadt V
,
Ayrault O
,
Swartling FJ
, ...,
Pfister SM
,
Northcott PA
Nat. Rev. Cancer
20
(1) 42-56 [2020-01-00; online 2019-12-09]
DOI
Crossref
Perturbation-based gene regulatory network inference to unravel oncogenic mechanisms
Morgan D
,
Studham M
,
Tjärnberg A
, ...,
Nordling TEM
,
Sonnhammer ELL
-
-
(-) - [2019-08-15; online 2019-08-15]
SciLifeLab Data Centre
Publications
9.5.1